Type V collagen-induced nasal tolerance prevents lung damage in an experimental model: new evidence of autoimmunity to collagen V in COPD
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Inducing immune tolerance to collagen V (Col V) can prevent chronic obstructive pulmonary disease (COPD) development and lung damage in mice exposed to cigarette smoke (CS). This suggests Col V autoimmunity contributes to COPD pathogenesis.
Area Of Science
- Immunology
- Pulmonology
- Pathogenesis of COPD
Background
- Chronic obstructive pulmonary disease (COPD) is linked to immune responses against self-antigens.
- Cigarette smoke (CS) exposure, a primary cause of COPD, induces lung inflammation and extracellular matrix (ECM) damage.
- This damage exposes collagen V (Col V), potentially triggering autoimmune responses implicated in lung diseases.
Purpose Of The Study
- To investigate the role of collagen V (Col V) autoimmunity in the development of COPD.
- To analyze the effects of Col V-induced immune tolerance on inflammatory responses and lung remodeling in a murine model of CS-induced COPD.
Main Methods
- Male C57BL/6 mice were exposed to CS for four weeks.
- One group received prior Col V tolerance induction before CS exposure.
- Lung function, structure, inflammatory markers, cytokines, and T-cell phenotypes were evaluated.
Main Results
- CS exposure led to structural ECM changes and increased pro-inflammatory responses, characteristic of COPD.
- Col V tolerance inhibited emphysema development and prevented ECM structural damage.
- Tolerance promoted an immunosuppressive lung microenvironment and induced regulatory T (Treg) cell differentiation.
Conclusions
- Induction of nasal tolerance to Col V can prevent inflammatory responses and lung remodeling in experimental COPD.
- These findings suggest that autoimmunity to Col V plays a significant role in COPD development.
- Col V tolerance represents a potential novel therapeutic strategy for COPD.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
• Inhalation of Irritants: Inhaling irritants, especially cigarette smoke, are primary causes of inflammation in COPD. Other irritants can include...
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Initiation of Airway Inflammation:
...
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...